PetVivo (NASDAQ:PETV) Trading Up 3.4%

PetVivo Holdings, Inc. (NASDAQ:PETV) shot up 3.4% on Wednesday . The stock traded as high as $0.76 and last traded at $0.74. 1,469 shares traded hands during trading, a decline of 97% from the average session volume of 51,394 shares. The stock had previously closed at $0.72.

PetVivo Stock Up 3.4 %

The company has a current ratio of 0.90, a quick ratio of 0.62 and a debt-to-equity ratio of 0.02. The stock’s 50-day moving average price is $0.91 and its 200-day moving average price is $1.04. The company has a market cap of $12.49 million, a P/E ratio of -0.87 and a beta of 2.15.

PetVivo (NASDAQ:PETV) last announced its quarterly earnings results on Monday, February 12th. The company reported ($0.12) earnings per share (EPS) for the quarter. The firm had revenue of $0.60 million during the quarter. PetVivo had a negative return on equity of 1,319.59% and a negative net margin of 1,016.64%.

Insider Activity at PetVivo

In other PetVivo news, CEO John Lai purchased 150,000 shares of the firm’s stock in a transaction on Monday, April 15th. The stock was acquired at an average price of $0.60 per share, for a total transaction of $90,000.00. Following the purchase, the chief executive officer now owns 1,288,592 shares of the company’s stock, valued at approximately $773,155.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 20.10% of the stock is currently owned by insiders.

Institutional Trading of PetVivo

A hedge fund recently bought a new stake in PetVivo stock. Warberg Asset Management LLC purchased a new position in shares of PetVivo Holdings, Inc. (NASDAQ:PETV) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,693 shares of the company’s stock, valued at approximately $29,000. Warberg Asset Management LLC owned approximately 0.19% of PetVivo at the end of the most recent quarter. Institutional investors own 24.55% of the company’s stock.

PetVivo Company Profile

PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.